V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20034946 | 20085935 | 1.55 | 73 | Palliative (P) | 2019-04-20 | 2019-04-22 | Carbo F | 01 | N | CABAZITAXEL | 100762009 |
| 20035008 | 20085936 | 1.84 | 82.9 | Palliative (P) | 2019-01-14 | 2019-02-01 | EEF or EOF | 01 | N | OXALIPLATIN | 101093242 |
| 20035022 | 20085938 | 1.68 | 108 | Palliative (P) | 2020-05-04 | 2020-05-10 | FOXTROT TRIAL | 02 | N | EVEROLIMUS | 101459082 |
| 20035061 | 20085939 | null | null | Adjuvant (A) | null | 2019-05-03 | Temozolomide + RT | N | N | IRINOTECAN | 100576147 |
| 20035102 | 20085941 | 1.55 | 66.9 | Curative (C) | 2019-03-16 | 2019-04-11 | PLATO Trials | 02 | N | PLATO TRIAL | 101472041 |
| 20035109 | 20085942 | 1.6 | 64.4 | Palliative (P) | 2020-01-17 | 2020-01-21 | null | 02 | N | GEMCITABINE + OXALIPLATIN | 100658713 |
| 20035110 | 20085943 | 1.45 | 76.15 | Curative (C) | 2020-12-15 | 2020-12-24 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | Y | CISPLATIN + DOXORUBICIN + FLUOROURACIL + VINCRISTINE | 101530112 |
| 20035181 | 20085944 | null | 91 | 03 | 2019-12-26 | 2020-01-02 | GEM-P | 02 | null | PEMBROLIZUMAB | 101167158 |
| 20035339 | 20085945 | 1.84 | 37.85 | 03 | 2016-08-31 | 2016-09-01 | CISPLATIN + FLUOROURACIL + RT | 2 | N | ECARBOX | 101752896 |
| 20035408 | 20085946 | 1.85 | 53.5 | Palliative (P) | 2019-02-27 | 2019-03-13 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | GEMCITABINE + PACLITAXEL | 100000150 |
| 20035464 | 20085947 | 1.73 | 82 | Curative (C) | 2019-07-16 | 2019-07-26 | Abiraterone | 02 | N | CABOZANTINIB | 100145539 |
| 20035482 | 20085948 | 1.63 | 105 | 03 | 2017-10-20 | 2017-10-20 | Fluorouracil + Folinic + RT Bossett | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101738260 |
| 20035490 | 20085949 | 0 | 0 | null | 2019-04-13 | 2019-04-23 | REGORAFENIB | 02 | N | FEC | 101639841 |
| 20035560 | 20085951 | 1.67 | 92.7 | Palliative (P) | 2019-10-07 | 2019-11-03 | Binimetinib + Cetuximab + Encorafenib | 02 | N | ACTICCA-1 TRIAL | 100425915 |
| 20035567 | 20085952 | 1.63 | 0 | Palliative (P) | 2016-04-12 | 2016-04-12 | IBRUTINIB | 02 | Y | CABAZITAXEL | 100824274 |
| 20035577 | 20085953 | 1.6 | 84.2 | Adjuvant (A) | 2018-11-19 | 2018-12-18 | FEC 100 | 02 | N | ESPAC TRIAL | 101311942 |
| 20035593 | 20085954 | 1.59 | 66 | Adjuvant (A) | 2020-11-25 | 2020-12-09 | CHOP - 21 days | 02 | N | GEMCITABINE + PACLITAXEL | 101669663 |
| 20035609 | 20085955 | null | null | 03 | 2019-04-29 | 2019-06-06 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 02 | N | CAPECITABINE + CISPLATIN + MITOMYCIN | 100815948 |
| 20035611 | 20085956 | 1.71 | 65 | 03 | 2018-07-03 | 2018-07-29 | Trastuzumab + VINORELBINE | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100452104 |
| 20035631 | 20085957 | 0 | 0 | Palliative (P) | 2016-03-31 | 2016-05-18 | NAB PACLITAXEL | 99 | N | CETUXIMAB + RT | 101496803 |
| 20035633 | 20085958 | 1.83 | 0 | Palliative (P) | 2016-09-04 | 2016-09-24 | ESPAC-4 TRIAL | 02 | N | CAPECITABINE + STREPTOZOCIN | 101858304 |
| 20035732 | 20085960 | 1.83 | 88 | 03 | 2016-07-12 | 2016-07-27 | OXALIPLATIN | N | null | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 101571820 |
| 20035784 | 20085961 | 1.86 | 94 | Palliative (P) | null | 2018-10-27 | Panitumumab | null | N | CISPLATIN + RT | 101868804 |
| 20035790 | 20085962 | 1.63 | 96.5 | 03 | 2022-01-17 | 2022-02-07 | EVEROLIMUS | N | N | GO2 TRIAL | 101719855 |
| 20035791 | 20085963 | 0 | 0 | 03 | 2018-07-27 | 2018-08-17 | IBRUTINIB | 01 | N | ECARBOX | 100077527 |
| 20035854 | 20085964 | 1.75 | 82 | Palliative (P) | 2016-06-16 | 2016-06-16 | NEO-AEGIS TRIAL | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101062346 |
| 20035880 | 20085965 | 1.57 | 89.1 | Adjuvant (A) | 2016-08-29 | 2016-08-29 | Carbo F | 02 | N | FLUOROURACIL + RT | 101758888 |
| 20035897 | 20085966 | 1.53 | 66.1 | null | 2019-05-04 | 2019-05-11 | REGORAFENIB | 02 | Y | CARBOPLATIN + RALTITREXED | 101771350 |
| 20035904 | 20085967 | 1.66 | 41.8 | 03 | 2019-08-27 | 2019-09-08 | Capital Trial | N | Y | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100976070 |
| 20035927 | 20085968 | 1.7 | 83.9 | Palliative (P) | 2016-08-06 | 2016-08-14 | Raltitrexed | Y | N | RITUXIMAB | 101566432 |
| 20035955 | 20085969 | 1.6 | 67 | 03 | 2019-05-27 | 2019-06-20 | BALLAD Trial | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101461223 |
| 20035963 | 20085970 | 1.69 | 79.9 | Palliative (P) | 2017-02-04 | 2017-02-25 | null | 01 | Y | PACLITAXEL | 100564974 |
| 20035970 | 20085971 | 1.75 | 55.5 | Palliative (P) | 2018-03-11 | 2018-04-14 | LENALIDOMIDE | 01 | N | CYCLOPHOSPHAMIDE | 100770103 |
| 20036006 | 20085973 | 1.82 | 102.8 | Palliative (P) | 2016-01-20 | 2016-01-22 | NEO-AEGIS TRIAL | 01 | N | CISPLATIN + FLUOROURACIL + RT | 100158889 |
| 20036034 | 20085974 | 1.55 | 92.7 | Adjuvant (A) | 2019-04-04 | 2019-04-21 | CARBOPLATIN + VINORELBINE | N | N | HEP SIOPEL 6 CISPLATIN | 101358868 |
| 20036045 | 20085975 | 1.73 | 96 | 03 | 2018-09-08 | 2018-09-15 | Raltitrexed | 02 | N | CARBOPLATIN + DOCETAXEL | 100967379 |
| 20036047 | 20085976 | 0 | 0 | 03 | 2020-12-04 | 2020-12-15 | CAPECITABINE + OXALIPLATIN + RT | 02 | N | CAPE + CETUXIMAB + OXALIPLATIN | 100883073 |
| 20036052 | 20085977 | 1.75 | 69 | Palliative (P) | 2016-09-01 | 2016-09-01 | BUSULFAN | 02 | N | MIC | 100148682 |
| 20036081 | 20085978 | 1.6 | 101 | null | 2018-08-27 | 2018-09-05 | NEO-ESCAPE TRIAL | 02 | null | ABC-08 TRIAL | 101826670 |
| 20036089 | 20085979 | 1.73 | 0 | 03 | 2019-03-03 | 2019-03-07 | CARBOPLATIN + FLUOROURACIL | N | N | DOCETAXEL | 100230482 |
| 20036101 | 20085980 | 1.65 | 60.6 | null | 2016-09-28 | 2016-10-12 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | Y | OXALIPLATIN | 101056347 |
| 20036130 | 20085981 | 1.73 | 66 | Palliative (P) | 2019-07-15 | 2019-08-26 | null | 02 | N | CARBO + FLUOROURACIL | 100415562 |
| 20036135 | 20085982 | 1.6 | 52.6 | Palliative (P) | 2016-11-13 | 2016-12-01 | Carboplatin + Vinorelbine IV | 02 | N | CAPECITABINE + CETUXIMAB + OXALIPLATIN | 101580546 |
| 20036144 | 20085983 | 1.55 | 53.6 | Palliative (P) | null | 2016-05-29 | EVEROLIMUS | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100158256 |
| 20036226 | 20085985 | 1.64 | 59.8 | Palliative (P) | 2017-10-19 | 2017-10-29 | Raltitrexed | 02 | N | EVEROLIMUS | 101801977 |
| 20036239 | 20085986 | null | 62 | null | 2018-11-01 | 2018-11-22 | IBRUTINIB | N | N | ERLOTINIB | 101765165 |
| 20036244 | 20085987 | 1.71 | 76.8 | Palliative (P) | 2018-07-12 | 2018-07-25 | PEMBROLIZUMAB | 02 | N | ARISTOTLE TRIAL | 101332157 |
| 20036248 | 20085988 | 1.71 | 64 | Palliative (P) | 2019-11-19 | 2019-11-19 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101745366 |
| 20036264 | 20085989 | 1.85 | 68.05 | Neo-adjuvant (N) | 2020-02-06 | 2020-02-06 | Docetaxel | 02 | Y | FCARBOST | 101036657 |
| 20036295 | 20085990 | 1.84 | 76 | null | 2018-08-23 | 2018-09-17 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 2 | N | CARBOPLATIN + FLUOROURACIL | 101698329 |